Please login to the form below

Not currently logged in
Email:
Password:

Catena

This page shows the latest Catena news and features for those working in and with pharma, biotech and healthcare.

BioMarin files muscular dystrophy drug in EU

BioMarin files muscular dystrophy drug in EU

Other companies bringing DMD therapies through the pipeline include Santhera, whose Raxone/Catena (idebenone) candidate has completed phase III testing.

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics